Fri.Jun 21, 2024

article thumbnail

Slideshow: Everything You Need to Know About the US Bird Flu Outbreak

Drug Topics

In a webinar conducted by the National Foundation for Infectious Diseases (NFID), experts gathered to publicly address the ongoing bird flu outbreak across many US states.

223
223
article thumbnail

BENEFIT Trial Results Show Quadruplet Regimen for NDMM TI May Require Weighing Efficacy vs Safety

Pharmacy Times

The quadruplet regimen added bortezomib to the current standard of care, which is a triplet regimen of isatuximab, lenalidomide, and dexamethasone for patients with transplant-ineligible, newly diagnosed multiple myeloma (NDMM TI).

139
139
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Slideshow: Exploring Cannabis Utilization in the Oncology Landscape

Drug Topics

Four abstracts presented at ASCO 2024 delved into cannabis and pain management, potential medication interactions, and symptom mitigation, in patients with cancer.

162
162
article thumbnail

STAT+: Vertex reports positive results in stem cell trial for type 1 diabetes

STAT

ORLANDO — Twelve people with type 1 diabetes who received a therapy derived from stem cells were able to produce enough of their own insulin to maintain healthy blood glucose levels 90 days later, Vertex Pharmaceuticals said Friday. All but one reduced or eliminated the need to inject insulin over those three months and three people followed for one year no longer needed to inject insulin at all.

145
145
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

FDA Commissioner Says the United States Is Failing the Type 2 Diabetes Epidemic

Pharmacy Times

With improved technology and innovations for diabetes, it is essential for health care providers and health agencies to collaborate to combat rising rates of diabetes.

FDA 138
article thumbnail

Supreme Court outlawed segregation of disabled people 25 years ago. But change has come slowly

STAT

As a toddler, Veronica Ayala loved Fridays. At 5 o’clock sharp, her mom whisked her away from the grim Moody State School for Cerebral Palsied Children for a 48-hour reprieve. Ayala’s house was mere minutes away, but the doctors insisted that she had to live at the Galveston, Texas institution during the week so she could learn how to walk.

143
143

More Trending

article thumbnail

Opinion: Medical experts must step up if health justice is to enter the courtroom

STAT

Danyel Smith has served 21 years of a life sentence at Dooly Correctional Facility in Unadilla, Georgia, for the 2003 murder of his two-month-old son, Chandler. The sole evidence against him at trial was the testimony of three physicians who said that child abuse — in this case shaken baby syndrome — was the only explanation for his son’s symptoms.

article thumbnail

‘A mixed bag’: Fifth Circuit rules on ACA preventive services legal case

Fierce Healthcare

The Fifth Circuit Court of Appeals has issued a decision in a major legal case that observers have said could fundamentally alter the preventive services provision in the Affordable Care Act. | The Fifth Circuit Court of Appeals has issued its ruling on Braidwood Management v. Becerra, a case that has wide-ranging implications on millions of Americans.

130
130
article thumbnail

STAT+: House panel weighs new plan for Medicare coverage of Wegovy, cancer blood tests

STAT

WASHINGTON — A House panel is exploring holding a vote on scaled-back versions of two major health care bills that would expand Medicare’s coverage of cancer screening tests and hugely popular weight loss drugs, five sources familiar with the planning told STAT. Full Medicare coverage for both items has broad bipartisan support, but the expansion has been hampered by the likely exorbitant price tags to the federal government.

142
142
article thumbnail

Virtual maternity care provider Pomelo clinches $46M to scale

Fierce Healthcare

Pomelo Care, a virtual value-based provider focused on maternal health, raised $46 million in a series B round to expand its care model and grow its headcount. | Pomelo offers virtual pregnancy, postpartum and infant care to patients between visits, while also analyzing claims and health record data to proactively identify individual risk factors.

125
125
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

‘We’re failing right now’ in type 2 diabetes, FDA chief says

STAT

ORLANDO — The United States is at a critical juncture in its efforts to treat chronic diseases, particularly type 2 diabetes, and now has a chance to change the dangerous trajectory it’s currently following, FDA Commissioner Robert Califf said Friday. “The U.S. is leading the world in technology development, innovation, new gadgets of all kinds, new drugs, you name it,” he said.

FDA 139
article thumbnail

African vaccine manufacturing initiative aims to provide $1B to local firms over next decade

Fierce Pharma

Amid an influx of efforts to help the African continent claim vaccine sovereignty, a new financing mechanism devised by Gavi, the Vaccine Alliance, the African Union and the Africa Centres for Dise | Amid an influx of efforts to help the African continent claim vaccine sovereignty, a new financing mechanism devised by Gavi, the Vaccine Alliance, the African Union and the Africa Centres for Disease Control and Prevention (Africa CDC) has taken flight.

Vaccines 122
article thumbnail

STAT+: Jury orders Stanford to pay millions to employee in racial harassment case

STAT

A jury has found Stanford University and Stanford Health Care liable for millions of dollars in damages to a longtime employee who sued the institution over its handling of racial harassment and discrimination against her a decade ago. After a seven-week trial, the jury ordered the award to be $20 million, but the Alameda County Superior Court concluded last week the award should be reduced to $10 million.

Hospitals 138
article thumbnail

Vertex clinches Trikafta and other cystic fibrosis drug reimbursement deal in England

Fierce Pharma

Cystic fibrosis (CF) patients and their families in England can rest a little easier this week, thanks to an extended long-term reimbursement deal inked by Vertex Pharmaceuticals and the country’s | Cystic fibrosis (CF) patients and their families in England can rest a little easier this week, thanks to an extended long-term reimbursement deal inked by Vertex Pharmaceuticals and the country’s National Health Service (NHS).

122
122
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

STAT+: Kaiser adds a small North Carolina health system to its Risant Health network

STAT

Kaiser Permanente on Friday announced the next deal to build out its Risant Health network of health systems. Risant plans to acquire North Carolina’s Cone Health, a Greensboro, N.C.-based system with four acute-care hospitals, more than 700 doctors, and — crucially for Risant — an accountable care organization and a health plan.

Hospitals 131
article thumbnail

Done responds to fraud charges, 'stands by' integrity of its services even as former employees raise the alarm

Fierce Healthcare

Telehealth startup Done said it "disagrees" with the criminal charges filed last week against its founder, Ruthia He, and David Brody, M.D., and plans to continue operating. | Telehealth startup Done said it "disagrees" with the criminal charges filed last week against its founder, Ruthia He, and David Brody, M.D. and plans to continue operating.

122
122
article thumbnail

STAT+: The CEO of Kaiser’s new health network shares why he’s making a bet on a tiny North Carolina hospital system

STAT

Outside of North Carolina, most people probably haven’t heard of Cone Health. But the relatively small system has an outsized reputation for keeping locals healthy and out of hospitals, according to the CEO of the health care network that struck a deal to acquire it. Improving health outcomes is the stated mission of that network, called Risant Health.

Hospitals 123
article thumbnail

Insights Into the Evolving Landscape of Hematology Treatment

Pharmacy Times

Tim Mok, PharmD, BCOP, BCPS, discusses innovative therapies that are changing the treatment options available for patients with hematologic malignancies.

123
123
article thumbnail

Opinion: ‘Patients like mine’ technologies must rest on solid evidence

STAT

Vendors of electronic health records and other health technology platforms have begun to publicize and demonstrate “patients like mine” capabilities, which insert analytics distilled from EHR data into the physician workflow to guide clinical decisions. While these implementations could be helpful, simple analytics must not be passed off as evidence, and care must be taken to rigorously implement and vet these tools to avoid the negative clinical and cost outcomes associated with i

119
119
article thumbnail

Navigating the Complex Landscape of Cell and Gene Therapy: Challenges and Solutions

Pharmacy Times

There are numerous challenges with cell and gene therapies in oncology, such as accessibility, cost, and prior authorizations, as well as the need for improved education and training within the oncology community.

156
156
article thumbnail

Can JAK inhibitors bolster checkpoint inhibitors? 

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Buenos dias! Writing from one of the more unique locations in my tenure as a Readout author… Hola from a mercado in Mexico City. On tap today: Early studies show that checkpoint inhibitors may be more effective if combined with JAK inhibitors.

115
115
article thumbnail

Industry Voices—The future of U.S. healthcare must be primary care-led

Fierce Healthcare

There is an old saying that if you do not make time for your wellness, you will be forced to make time for your illness. | The time has come to recognize the power of primary care to lead transformation of the U.S. healthcare system.

113
113
article thumbnail

STAT+: Federal judge rules in favor of hospital lobby in privacy lawsuit

STAT

A federal judge has sided with a powerful hospital lobby in a legal battle with regulators over hospitals’ use of third-party website trackers to gather details about visitors’ online behavior. North Texas U.S. District Court Judge Mark Pittman ruled that federal guidance limiting hospital websites’ use of these trackers exceeds the Health and Human Services Department’s authority under HIPAA, according to an opinion filed Thursday.

Hospitals 113
article thumbnail

The new genomic frontier: Next-generation data management takes flight

pharmaphorum

Explore the latest advancements in genomics and sequencing technologies, and learn how next-generation data management tools are transforming genomic research and applications in this new genomic frontier.

112
112
article thumbnail

A closer look at 'friend-shoring' and the drug shortage challenge

Fierce Pharma

In this week’s episode of “The Top Line,” Fierce Pharma’s Zoey Becker sits down with Bobby Sheng, the CEO of Bora Pharmaceuticals, to discuss the concept of “friend-shoring” in drug manufacturing.< | In this week’s episode of “The Top Line,” Fierce Pharma’s Zoey Becker sits down with Bobby Sheng, the CEO of Bora Pharmaceuticals, to discuss the concept of “friend-shoring” in drug manufacturing.

109
109
article thumbnail

Can you eat popcorn if you have diabetes?

The Checkup by Singlecare

If you’re managing Type 2 diabetes , choosing foods that help regulate blood glucose levels is essential. According to the American Diabetes Association , the best food choices for people with diabetes include whole grains, lean proteins, healthy fats, and non-starchy vegetables. Foods that are high in fiber and low in sugar are good snack options for individuals with diabetes because they help prevent rapid increases in blood sugar levels, improve heart health, and assist with weight mana

111
111
article thumbnail

STAT+: Up and down the ladder: The latest comings and goings

STAT

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

110
110
article thumbnail

New Innovative Treatments Are On The Horizon for Diabetic Kidney Disease

Pharmacy Times

Presenters at the American Diabetes Association 84th Scientific Sessions, analyzed potential developments in treatment for patients with diabetes and diabetic kidney disease.

111
111
article thumbnail

STAT+: Pharmalittle: We’re reading about FDA approval for Sarepta drug, MSF closing access campaign and more

STAT

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda, so far, appears quite modest. We hope to tidy up around the castle, promenade with the official mascots and hold another listening party, where the rotation will likely include this , this , this , this and this.

FDA 104
article thumbnail

5 Key Sessions and Interviews at McKesson ideaShare 2024

Pharmacy Times

Pharmacy Times will be at McKesson ideaShare 2024 Conference in New Orleans, Louisiana from June 23 to June 26, 2024.

123
123
article thumbnail

Argenx's Vyvgart Hytrulo snares 2nd US nod as FDA gives green light in autoimmune disease CIDP

Fierce Pharma

For more than a decade, argenx has sought to apply its novel antibody fragment treat | Argenx's Vyvgart has won approval to treat its second indication in the U.S. and its third globally after the U.S. FDA cleared the med to treat the rare and debilitating peripheral nervous system disease chronic inflammatory demyelinating polyneuropathy (CIDP).

FDA 98
article thumbnail

Expert: Pharmacists Play Key Role in Diabetes Management and Treatment Adherence

Pharmacy Times

American Diabetes Association Scientific Sessions speaker Ivan de Araujo emphasizes the importance of the pharmacist’s role in diabetes care and his hopes for the future of care.

101
101
article thumbnail

Sustainable innovation for patients, people, and planet

pharmaphorum

Sustainability is all important for the planet and its people, and in today’s podcast web editor Nicole Raleigh speaks with Harriet Lewis, director of public affairs and communications at Chiesi UK & Ireland, about how partnerships between the NHS and pharma industry can support the journey to more sustainable practices, from R&D and drug reimbursement to medicines and recycling.

article thumbnail

Gilead small molecule demonstrates strong capability for HIV prevention

European Pharmaceutical Review

Gilead Sciences ’ twice-yearly injectable HIV-1 capsid inhibitor enabled 100 percent efficacy for investigational use of HIV prevention in cisgender women. This is according to interim analysis topline results of the Phase III PURPOSE 1 trial. Lenacapavir showed superiority to once-daily oral Truvada ® (emtricitabine 200mg and tenofovir disoproxil fumarate 300mg; F/TDF) and background HIV incidence (bHIV).